Multiple antigen binding molecules, whose activity can replace the action of blood coagulation factor VIII (FVII) and pharmaceutical formulations containing such molecules as active ingredients
The invention refers to two kinds of antibodies, of which the inhibition and activation activity of pentachlorobenzene is not high, and the activity of substituting FVII is very high.La presente invención se refiere a anticuerpos biespecíficos cuya actividad inhibidora de activación de FIX no es elevada y cuya actividad de sustitución de la función de cofactor FVIII es elevada.